ABSORB II Randomized Controlled Trial

Inclusion Criteria: General Inclusion Criteria * Subject must be at least 18 years of age and less than 85 years of age. * Subject must agree not to participate in any other clinical investigation for a period of three years following the index procedure. This includes clinical trials of medication and invasive procedures. Questionnaire-based studies, or other studies that are non-invasive and do not require medication are allowed. * Subject is able to verbally confirm understanding of risks, benefits and treatment alternatives of receiving the ABSORB BVS system and he/she or his/her legally authorized representative provides written informed consent prior to any Clinical Investigation related procedure, as approved by the appropriate Ethics Committee. * Subject must have evidence of myocardial ischemia (e.g., stable or unstable angina, silent ischemia). * Subject must be an acceptable candidate for coronary artery bypass graft (CABG) surgery * Subject must agree to undergo all clinical investigation plan-required follow-up visits, exercise testing, blood draw as well as adherence to European Society of Cardiology Guidelines and completion of quality of life questionnaires and of a subject diary to collect information including but not limited to tobacco usage, food intake, daily exercise and body weight Angiographic Inclusion Criteria * One or two de novo native lesions each located in a different epicardial vessel. * If two treatable lesions meet the eligibility criteri…